Climb Bio, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
CLYM on Nasdaq
Industry
Pharmaceutical Preparations
Location
20 William Street, Suite 145, Wellesley Hills, MA

Insiders trading volume in the past year

Climb Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ai Eti Llc 10%+ Owner $62.6M Aug 12, 2021
Ra Capital Management, L.P. Director, 10%+ Owner $11M Jun 4, 2025
Aoife Brennan President and CEO, Director $2.04M -$25.2K -1.22% Jun 27, 2025
Brett Kaplan Chief Operating Officer $618K Jan 13, 2025
Stephen Basil Thomas Director $420K Aug 7, 2025
Valerie Morisset Evp, R&D And Cso $250K Jul 19, 2024
Emily Pimblett SVP, Finance & CAO $63.8K -$5.61K -8.07% Jun 18, 2025
Alexander Cumbo Director Jun 4, 2025
Kimberlee C. Drapkin Director Jun 4, 2025
Judith Dunn Director Jun 4, 2025
Andrew David Levin Director Jun 4, 2025
Susan ALTSCHULLER Chief Financial Officer Oct 1, 2025
Cindy Driscoll Senior Vice President, Finance Jun 17, 2025
Perrin Megan Wilson Chief Business Officer Jun 17, 2025
Douglas E. Williams Director Jun 4, 2025
James Bucher EVP and General Counsel Oct 31, 2022
Simon Tate Director Jun 26, 2024
Leone D. Patterson Director May 19, 2022
Adam Joseph Rosenberg Director Jun 26, 2024
Liam Ratcliffe Director Jun 26, 2024
Robert Azelby President & CEO, Director Oct 31, 2022
Erin Lavelle Coo & Cfo Oct 31, 2022

Recent Insider Transactions by Companies or Individuals for Climb Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.